Arriello to Speak at the PV UK & EU 2026 Conference as Silver Sponsor.
Arriello is pleased to announce that Humaira Qureshi, Chief Operating Officer, will be attending the 40th Pharmacovigilance UK & EU 2026 conference, hosted by Virtue Insight in London on 11–12 March, 2026. Arriello is also proud to be a Silver Sponsor of the event.
Humaira will participate as a panellist in the Audits & Inspections session, joining industry leaders to discuss PV audit strategy, inspection readiness, and evolving regulatory expectations across global markets.
In addition, Humaira will deliver a speaking session titled:
Planning and Managing Audits and Inspections – A Service Provider Viewpoint.
Her presentation will explore how pharmacovigilance service providers have adapted in response to accelerated geo-expansion, upskilling, organisational restructuring, and increasing regulatory scrutiny. The session will address what good looks like in today’s PV landscape, including the role of technology in audit management, ensuring inspection readiness, and managing the growing demand for local, regional, and global representation.
As pharmacovigilance continues to evolve — shaped by digital transformation, AI-enabled systems, and increasing regulatory complexity — strong governance, operational excellence, and strategic audit management remain central to maintaining trust and safeguarding patient safety.
Humaira looks forward to connecting with industry peers and contributing to discussions that will help shape the future of pharmacovigilance across the UK, EU, and beyond.
The 40th Pharmacovigilance UK & EU 2026 conference, hosted by Virtue Insight, brings together senior leaders from across pharma, biotech, and regulatory authorities to explore the future of patient safety. Taking place in London, the two-day event will address key industry themes including audits and inspections, regulatory strategy, AI and automation in pharmacovigilance, risk management, signal detection, outsourcing, and the evolving global compliance landscape.
As a Silver Sponsor of the event, Arriello is proud to support industry collaboration and contribute to conversations shaping the future of pharmacovigilance. Through its global regulatory and drug safety expertise, Arriello remains committed to delivering inspection-ready, compliant, and patient-focused solutions across international markets.
With more than two decades of leadership experience across pharmacovigilance (PV), regulatory affairs, and medical information services, Humaira brings a proven track record of driving operational excellence and delivering transformative, tech-enabled safety and compliance solutions to global clients.
Humaira joins Arriello following senior executive roles where she led global teams of more than 1,500 professionals and partnered with worldwide clients to deliver high-impact safety, compliance, and technology-led initiatives.
Recognized for her strategic vision and consultative approach, Humaira has been instrumental in modernizing traditional PV service models and integrating digital tools to enhance operational agility and data-driven decision-making.
Latest News:
